These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24086683)

  • 1. Anti-HIV activity of human defensin 5 in primary CD4+ T cells under serum-deprived conditions is a consequence of defensin-mediated cytotoxicity.
    Ding J; Tasker C; Valere K; Sihvonen T; Descalzi-Montoya DB; Lu W; Chang TL
    PLoS One; 2013; 8(9):e76038. PubMed ID: 24086683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neisseria gonorrhoeae-induced human defensins 5 and 6 increase HIV infectivity: role in enhanced transmission.
    Klotman ME; Rapista A; Teleshova N; Micsenyi A; Jarvis GA; Lu W; Porter E; Chang TL
    J Immunol; 2008 May; 180(9):6176-85. PubMed ID: 18424739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key Determinants of Human α-Defensin 5 and 6 for Enhancement of HIV Infectivity.
    Valere K; Lu W; Chang TL
    Viruses; 2017 Aug; 9(9):. PubMed ID: 28850095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HIV-1 infection by human α-defensin-5, a natural antimicrobial peptide expressed in the genital and intestinal mucosae.
    Furci L; Tolazzi M; Sironi F; Vassena L; Lusso P
    PLoS One; 2012; 7(9):e45208. PubMed ID: 23028850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human defensins 5 and 6 enhance HIV-1 infectivity through promoting HIV attachment.
    Rapista A; Ding J; Benito B; Lo YT; Neiditch MB; Lu W; Chang TL
    Retrovirology; 2011 Jun; 8():45. PubMed ID: 21672195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Alpha-Defensin HNP1 Increases HIV Traversal of the Epithelial Barrier: A Potential Role in STI-Mediated Enhancement of HIV Transmission.
    Valere K; Rapista A; Eugenin E; Lu W; Chang TL
    Viral Immunol; 2015 Dec; 28(10):609-15. PubMed ID: 26379091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity.
    Chang TL; Vargas J; DelPortillo A; Klotman ME
    J Clin Invest; 2005 Mar; 115(3):765-73. PubMed ID: 15719067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neisseria gonorrhoeae enhances HIV-1 infection of primary resting CD4+ T cells through TLR2 activation.
    Ding J; Rapista A; Teleshova N; Mosoyan G; Jarvis GA; Klotman ME; Chang TL
    J Immunol; 2010 Mar; 184(6):2814-24. PubMed ID: 20147631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions.
    Porter E; Yang H; Yavagal S; Preza GC; Murillo O; Lima H; Greene S; Mahoozi L; Klein-Patel M; Diamond G; Gulati S; Ganz T; Rice PA; Quayle AJ
    Infect Immun; 2005 Aug; 73(8):4823-33. PubMed ID: 16040996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.
    Wang A; Chen F; Wang Y; Shen M; Xu Y; Hu J; Wang S; Geng F; Wang C; Ran X; Su Y; Cheng T; Wang J
    J Virol; 2013 Mar; 87(5):2835-45. PubMed ID: 23269800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivalent binding of carbohydrates by the human alpha-defensin, HD5.
    Lehrer RI; Jung G; Ruchala P; Andre S; Gabius HJ; Lu W
    J Immunol; 2009 Jul; 183(1):480-90. PubMed ID: 19542459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-defensin HD5 inhibits furin cleavage of human papillomavirus 16 L2 to block infection.
    Wiens ME; Smith JG
    J Virol; 2015 Mar; 89(5):2866-74. PubMed ID: 25540379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human α-defensin-derived peptide HD5(1-9) inhibits cellular attachment and entry of human cytomegalovirus.
    Böffert R; Businger R; Preiß H; Ehmann D; Truffault V; Simon C; Ruetalo N; Hamprecht K; Müller P; Wehkamp J; Schindler M
    Antiviral Res; 2020 May; 177():104779. PubMed ID: 32209394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors.
    Mackewicz CE; Yuan J; Tran P; Diaz L; Mack E; Selsted ME; Levy JA
    AIDS; 2003 Sep; 17(14):F23-32. PubMed ID: 14502030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Defensin HD5 Inhibits Human Papillomavirus 16 Infection via Capsid Stabilization and Redirection to the Lysosome.
    Wiens ME; Smith JG
    mBio; 2017 Jan; 8(1):. PubMed ID: 28119475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased turnover of CCR5+ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection.
    Zaunders JJ; Kaufmann GR; Cunningham PH; Smith D; Grey P; Suzuki K; Carr A; Goh LE; Cooper DA
    J Infect Dis; 2001 Mar; 183(5):736-43. PubMed ID: 11181150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of human α-defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs.
    Mathew B; Nagaraj R
    Peptides; 2015 Sep; 71():128-40. PubMed ID: 26206286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sub-inhibitory concentrations of human α-defensin potentiate neutralizing antibodies against HIV-1 gp41 pre-hairpin intermediates in the presence of serum.
    Demirkhanyan L; Marin M; Lu W; Melikyan GB
    PLoS Pathog; 2013; 9(6):e1003431. PubMed ID: 23785290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the Interaction of Tumor-Derived HD5 Alpha Defensins with Adenoviruses and Implications for Oncolytic Adenovirus Therapy.
    Vragniau C; Hübner JM; Beidler P; Gil S; Saydaminova K; Lu ZZ; Yumul R; Wang H; Richter M; Sova P; Drescher C; Fender P; Lieber A
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of HIV peptide antigen specific cellular immune response by synthetic α- and β-defensin peptides.
    Mohan T; Sharma C; Bhat AA; Rao DN
    Vaccine; 2013 Mar; 31(13):1707-16. PubMed ID: 23384751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.